相关实验视频

Updated: Jun 23, 2025

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

适合特定用途的异构单域抗体,用于胃肠道向来自Clostridium difficile的毒素B

Everardo R Rodriguez Rodriguez¹, Rune Thorbjørn Nordvang¹, Marcus Petersson^1,2

¹Bactolife A/S, Copenhagen East, Denmark.

Protein science : a publication of the Protein Society

|June 26, 2024

概括

我们开发了一种方法来制造稳定,口服输送的单域抗体 (sdAbs) 以促进肠道健康. 这些VHH结构在具有挑战性的胃肠道疾病中有效地中和了Clostridium difficile毒素.

科学领域:

免疫学免疫学免疫学
生物技术是生物技术.
微生物学微生物学

背景情况:

单域抗体 (sdAbs),包括VHHs,对抗病原体的胃肠道 (GI) 应用有希望.
对于GI特异性蛋白质应用的可开发性概况尚未得到很好的定义.

研究的目的:

建立一种体外方法来识别具有优越可用于口服和胃肠道功能的SDAb衍生物.
开发一种针对Clostridium difficile毒素B (TcdB) 的VHH结构,用于增强肠道健康应用.

主要方法:

开发双价值VHH结构以提高可开发性.
在实验室中评估VHH稳定性和结合活性在模拟的GI条件下 (胃pH,胆盐,高温).
针对三种TcdB毒素型的甘基转移酶域 (GTD) 的异构HHH结构的表征.

主要成果:

成功开发了一种异构的VHH结构,抑制了多种TcdB毒素型的毒性活性.
在模拟的胃条件,胆汁盐和高温下,VHH结构显示出高稳定性和结合效率.
该方法方便识别具有优异口服和肠道功能的sdAb衍生物.

结论:

早期纳入可开发性评估可以简化VHH和口腔GI应用的相关构造的发现.
开发的VHH结构显示了对Clostridium difficile感染的治疗用途的潜力.
试管婴儿方法提供了一个强大的平台,用于设计GI稳定的生物制剂.

关键词:

克洛斯特里迪亚姆困难菌 (Clostridium difficile) 是一种难以灭绝的菌种.抗体是一种抗体.胆盐的稳定性胆盐的稳定性开发能力开发能力通过口服进行口服管理.一个单域抗体.

更多相关视频

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Antibody Actions

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...